A Study of Vedolizumab SC Given to Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease in South Korea

Abroad (travel likely)Recruiting

Conditions

Ulcerative Colitis · Crohn's Disease · Inflammatory Bowel Disease (IBD)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Donggguk University Ilsan Hospital, Goyang-si, Gyeonggi-do, South Korea
Contact: Study coordinator (Site Contact) · drlimyj@gmail.com · 010-2533-6288
Contact: Principal Investigator (Yoon-Jung Lim, Prof.)

Study leads

Study Director
Takeda

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

AIM-IBD: A Microbiome-Targeted Supplement in Mild-to-Moderate Ulcerative Colitis

Ulcerative Colitis (UC) · Inflammatory Bowel Disease (IBD) · Colitis

Abroad (travel likely)Recruiting

Izmir, Turkey (Türkiye)

Interleukin-23 Monoclonal Antibody for Inflammatory Bowel Disease: Efficacy and Safety

Crohn's Disease and Ulcerative Colitis

Abroad (travel likely)RecruitingPHASE4

Guangzhou, China

TIDHI Mental Health in IBD Patients Study

Crohn Disease (CD) · Ulcerative Colitis (UC) · Inflammatory Bowel Disease (IBD)

Abroad (travel likely)Recruiting

North York, Canada

Longitudinal Study on Bacterial Production of LPC and LPA in Patients With Inflammatory Bowel Disease

Inflammatory Bowel Diseases · Crohn's Disease · Ulcerative Colitis

Abroad (travel likely)Recruiting

Hamilton, Canada